Emicizumab for the treatment of haemophilia A: a narrative review

One of the most serious complications of the treatment of severe haemophilia A is the development of alloantibodies against exogenous factor VIII (FVIII). Inhibitors render factor replacement therapy ineffective, exposing patients to a remarkably high risk of morbidity and mortality. Besides the wel...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Transfus
Egile Nagusiak: Franchini, Massimo, Marano, Giuseppe, Pati, Ilaria, Candura, Fabio, Profili, Samantha, Veropalumbo, Eva, Masiello, Francesca, Catalano, Liviana, Piccinini, Vanessa, Vaglio, Stefania, Pupella, Simonetta, Liumbruno, Giancarlo M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Edizioni SIMTI - SIMTI Servizi Srl 2019
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6596376/
https://ncbi.nlm.nih.gov/pubmed/31246563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2019.0026-19
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak